Evaluation of the effects of curcumin-piperine in reducing Pseudomonas infection and improving clinical outcome in patients with cystic fibrosis

Mashhad University of Medical Sciences0 个研究点目标入组 138 人开始时间: 待定最近更新: 2023年2月7日

适应症

试验速览

暂无简介。

•Cystic fibrosis patients who have been diagnosed based on clinical symptoms and sweat test.
•5 years and above.
•Have pulmonary and gastrointestinal problems.
•able to perform the spirometry maneuver and have at least FEV1 greater than or equal to 30% based on the normal population based on age, gender and height.
•The percentage of oxygen saturation based on pulse oximetry should be greater than or equal to 90% at room temperature.
•be clinically stable.
•Informed consent has been obtained from the patients.
•Do not have heart, liver or kidney failure.
•Do not have celiac disease.
•No evidence of acute pulmonary exacerbation that requiring hospitalization in last past 4 weeks.
•Do not have evidence of severe complications of pulmonary disease including severe hemoptysis or pneumothorax during the last 2 months.

发起方